RHB Retail Research
Trading Stocks - Duopharma Biotech
Duopharma Biotech may climb higher after forming a white candle and hitting its new 52-week high. With the 21-day SMA line edging upwards, this implies a positive outlook. A positive bias may emerge above the MYR1.58 level, with an exit set below the MYR1.51 threshold. Towards the upside, the immediate resistance is at the MYR1.70 mark. This is followed by the MYR1.80 level.
Source: RHB Securities Research - 10 Jan 2020
More articles on RHB Retail Research
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
CEO Morning Brief
PGF Capital to Distribute Thermal Insulated Panels for Data Centres
3
Bimb Research Highlights
4
Bimb Research Highlights
5
Rakuten Trade Research Reports
6
7
Bimb Research Highlights
8
The Alpha Trader
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
MQ Trading Signals
Stock
Time
Signal
Duration
Stock
Time
Signal
Duration
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
